Our team of chemists recently reported a detailed analysis of Excel’s core weaknesses when used in pharmaceutical development as compared to ACD/Labs Luminata, as well as ELNs, CDSs, and LIMSs. Here are seven of Excel’s most pressing shortcomings that were identified in the paper.
The rapid increase in biopharmaceutical approvals and sales indicates their tremendous opportunities in the coming years. Innovative software solutions play an essential role in unlocking that potential. Learn more about how ACD/Labs brings chemical intelligence to biopharmaceutical research in this blog post.
This article provides an overview of why digitalized data management in the pharmaceutical industry is challenging and explores how effective data management can enhance drug quality.
Eliot Randle and Joe DiMartino discuss why biopharmaceutical companies are excited about Antibody-Drug Conjugates (ADCs), and how collaborative development is strategically important in ADC research.
Sanji Bhal spoke with our experts Joe DiMartino and Andrew Anderson about overcoming supply chain challenges and actionable steps to increase efficiency within pharmaceutical organizations. Read what they had to say.
At a time when the world is watching and expecting lightning fast results from drug development for SARS-COV-2 therapies I am reflecting on the impediments drug development teams face in releasing an antiviral drug quickly while keeping safety and quality at the forefront.